97 Treatment of chronic myelogenous leukemia (CML) relapsing after myeloablative stem cell transplantation with STI-571 (imatinib mesylate) with or without donor lymphocyte infusion (DLI)
Year: 2003
Type: article
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2009188271